Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical TrialJAMA 2021 Apr 13;325(14)1414-1425, D Rubino, N Abrahamsson, M Davies, D Hesse, FL Greenway, C Jensen, I Lingvay, O Mosenzon, J Rosenstock, MA Rubio, G Rudofsky, S Tadayon, TA Wadden, D Dicker, STEP 4 Investigators
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.